183 related articles for article (PubMed ID: 28212728)
1. Metabolic pathways regulated by p63.
Candi E; Smirnov A; Panatta E; Lena AM; Novelli F; Mancini M; Viticchiè G; Piro MC; Di Daniele N; Annicchiarico-Petruzzelli M; Melino G
Biochem Biophys Res Commun; 2017 Jan; 482(3):440-444. PubMed ID: 28212728
[TBL] [Abstract][Full Text] [Related]
2. p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival.
Coates PJ; Nenutil R; Holcakova J; Nekulova M; Podhorec J; Svoboda M; Vojtesek B
Virchows Arch; 2018 Mar; 472(3):351-359. PubMed ID: 29484502
[TBL] [Abstract][Full Text] [Related]
3. The foggy world(s) of p63 isoform regulation in normal cells and cancer.
Pokorná Z; Vysloužil J; Hrabal V; Vojtěšek B; Coates PJ
J Pathol; 2021 Jul; 254(4):454-473. PubMed ID: 33638205
[TBL] [Abstract][Full Text] [Related]
4. p63 supports aerobic respiration through hexokinase II.
Viticchiè G; Agostini M; Lena AM; Mancini M; Zhou H; Zolla L; Dinsdale D; Saintigny G; Melino G; Candi E
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):11577-82. PubMed ID: 26324887
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of p63 isoforms in normal tissues and neoplastic cells.
Nylander K; Vojtesek B; Nenutil R; Lindgren B; Roos G; Zhanxiang W; Sjöström B; Dahlqvist A; Coates PJ
J Pathol; 2002 Dec; 198(4):417-27. PubMed ID: 12434410
[TBL] [Abstract][Full Text] [Related]
6. [Application of PLA Method for Detection of p53/p63/p73 Complexes in Situ in Tumour Cells and Tumour Tissue].
Hrabal V; Nekulová M; Nenutil R; Holčaková J; Coates PJ; Vojtěšek B
Klin Onkol; 2017; 30(Supplementum1):159-162. PubMed ID: 28471195
[TBL] [Abstract][Full Text] [Related]
7. Hsp70 acts as a fine-switch that controls E3 ligase CHIP-mediated TAp63 and ΔNp63 ubiquitination and degradation.
Wu HH; Wang B; Armstrong SR; Abuetabh Y; Leng S; Roa WHY; Atfi A; Marchese A; Wilson B; Sergi C; Flores ER; Eisenstat DD; Leng RP
Nucleic Acids Res; 2021 Mar; 49(5):2740-2758. PubMed ID: 33619536
[TBL] [Abstract][Full Text] [Related]
8. p63-related signaling at a glance.
Fisher ML; Balinth S; Mills AA
J Cell Sci; 2020 Sep; 133(17):. PubMed ID: 32917730
[TBL] [Abstract][Full Text] [Related]
9. p63: a crucial player in epithelial stemness regulation.
Li Y; Giovannini S; Wang T; Fang J; Li P; Shao C; Wang Y; ; Shi Y; Candi E; Melino G; Bernassola F
Oncogene; 2023 Nov; 42(46):3371-3384. PubMed ID: 37848625
[TBL] [Abstract][Full Text] [Related]
10. The promyelocytic leukaemia protein tumour suppressor functions as a transcriptional regulator of p63.
Bernassola F; Oberst A; Melino G; Pandolfi PP
Oncogene; 2005 Oct; 24(46):6982-6. PubMed ID: 16007146
[TBL] [Abstract][Full Text] [Related]
11. Characterization of specific p63 and p63-N-terminal isoform antibodies and their application for immunohistochemistry.
Nekulova M; Holcakova J; Nenutil R; Stratmann R; Bouchalova P; Müller P; Mouková L; Coates PJ; Vojtesek B
Virchows Arch; 2013 Sep; 463(3):415-25. PubMed ID: 23887585
[TBL] [Abstract][Full Text] [Related]
12. p63 isoforms regulate metabolism of cancer stem cells.
D'Aguanno S; Barcaroli D; Rossi C; Zucchelli M; Ciavardelli D; Cortese C; De Cola A; Volpe S; D'Agostino D; Todaro M; Stassi G; Di Ilio C; Urbani A; De Laurenzi V
J Proteome Res; 2014 Apr; 13(4):2120-36. PubMed ID: 24597989
[TBL] [Abstract][Full Text] [Related]
13. Caspase-1 is a novel target of p63 in tumor suppression.
Celardo I; Grespi F; Antonov A; Bernassola F; Garabadgiu AV; Melino G; Amelio I
Cell Death Dis; 2013 May; 4(5):e645. PubMed ID: 23703390
[TBL] [Abstract][Full Text] [Related]
14. The diverse oncogenic and tumour suppressor roles of p63 and p73 in cancer: a review by cancer site.
Orzol P; Holcakova J; Nekulova M; Nenutil R; Vojtesek B; Coates PJ
Histol Histopathol; 2015 May; 30(5):503-21. PubMed ID: 25510918
[TBL] [Abstract][Full Text] [Related]
15. Possible Usage of p63 in Bioptic Diagnostics.
Galoczová M; Nenutil R; Coates P; Vojtěšek B
Klin Onkol; 2018; 31(Suppl 2):27-31. PubMed ID: 31023021
[TBL] [Abstract][Full Text] [Related]
16. One, two, three--p53, p63, p73 and chemosensitivity.
Müller M; Schleithoff ES; Stremmel W; Melino G; Krammer PH; Schilling T
Drug Resist Updat; 2006 Dec; 9(6):288-306. PubMed ID: 17287142
[TBL] [Abstract][Full Text] [Related]
17. A double dealing tale of p63: an oncogene or a tumor suppressor.
Chen Y; Peng Y; Fan S; Li Y; Xiao ZX; Li C
Cell Mol Life Sci; 2018 Mar; 75(6):965-973. PubMed ID: 28975366
[TBL] [Abstract][Full Text] [Related]
18. Frequent alteration of p63 expression in human primary bladder carcinomas.
Park BJ; Lee SJ; Kim JI; Lee SJ; Lee CH; Chang SG; Park JH; Chi SG
Cancer Res; 2000 Jul; 60(13):3370-4. PubMed ID: 10910040
[TBL] [Abstract][Full Text] [Related]
19. p63 regulates proliferation and differentiation of developmentally mature keratinocytes.
Truong AB; Kretz M; Ridky TW; Kimmel R; Khavari PA
Genes Dev; 2006 Nov; 20(22):3185-97. PubMed ID: 17114587
[TBL] [Abstract][Full Text] [Related]
20. Overexpression and ratio disruption of ΔNp63 and TAp63 isoform equilibrium in endometrial adenocarcinoma: correlation with obesity, menopause, and grade I/II tumors.
Vakonaki E; Soulitzis N; Sifakis S; Papadogianni D; Koutroulakis D; Spandidos DA
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1271-8. PubMed ID: 22441934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
